Trusted by over 25 global biopharmaceutical companies and CROs to successfully leverage medical imaging in their clinical trials.
Without a Medical Physics Expert (MPE) and Clinical Radiation Expert (CRE) on staff, you need a partner with the expertise to review your trial details to ensure the safety of all patients and participants.
When relying on routine channels to assist with reviews, turnaround time can be unpredictable and lengthy, often leading to delays in reaching the next REC deadline.
Successful clinical trials demand greater numbers of medical images at faster speeds and with increased accuracy, but many healthcare, pharma and CROs lack precise in-house imaging expertise across the wide range of sub-specialties that general radiologists cannot cover.
Nclusiv offers HRA dually accredited MPEs and CREs supporting Pharma, CROs, NHS Clinical Trial Units handling hundreds of trial reviews annually.
We offer a completely free introductory discussion call to address your individual needs. Sign up by filling in the quick form here:
1. Requirements assessment — We evaluate your trial's imaging requirements and identify the appropriate specialist expertise needed
2. Specialist allocation — We assign HRA dually accredited MPEs or CREs with relevant experience to your specific imaging modalities
3. Rapid review delivery — Complete reviews provided within 2-5 days, with urgent reviews available within 24 hours
4. Regulatory guidance — Expert support through IRAS submission or HRA self-managed processes as required
5. Query resolution — Any questions or amendments addressed within 24 hours to maintain timeline momentum
6. Submission support — Ongoing assistance through the regulatory approval process until successful completion
Download our comprehensive service brochure for detailed information on our methodology, case studies, and pricing:
Our expert reviews can be tailored to address different aspects of your imaging requirements:
We believe that expert radiation assurance should accelerate, not delay, your clinical trial progress.